| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 60.908 | 67.956 | 81.019 | 97.594 | 124.820 | 106.613 | 134.817 | 156.405 | 151.637 | 169.341 |
| Total Income - EUR | 60.908 | 71.363 | 81.020 | 99.598 | 124.821 | 111.492 | 134.818 | 156.405 | 153.416 | 192.188 |
| Total Expenses - EUR | 46.555 | 46.057 | 50.921 | 39.949 | 52.562 | 45.831 | 38.011 | 66.919 | 78.397 | 99.992 |
| Gross Profit/Loss - EUR | 14.353 | 25.306 | 30.099 | 59.650 | 72.259 | 65.661 | 96.807 | 89.486 | 75.019 | 92.196 |
| Net Profit/Loss - EUR | 12.526 | 23.165 | 29.289 | 58.654 | 71.011 | 64.843 | 95.486 | 87.954 | 73.728 | 87.330 |
| Employees | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Oftamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.836 | 23.767 | 20.644 | 16.918 | 21.222 | 36.942 | 90.802 | 80.068 | 242.182 | 214.792 |
| Current Assets | 13.164 | 6.012 | 23.640 | 45.025 | 54.661 | 29.442 | 21.136 | 17.478 | 30.916 | 62.644 |
| Inventories | 1.185 | 333 | 161 | 7.657 | 1.190 | 1.228 | 2.432 | 3.808 | 5.181 | 6.052 |
| Receivables | 8.942 | 2.784 | 2.703 | 19.591 | 27.427 | 9 | 8.557 | 5.630 | 13.008 | 725 |
| Cash | 3.036 | 2.896 | 20.776 | 17.777 | 26.044 | 28.205 | 10.147 | 8.041 | 12.726 | 55.867 |
| Shareholders Funds | 33.280 | 23.241 | 29.363 | 58.727 | 71.087 | 64.918 | 95.558 | 88.027 | 100.839 | 87.491 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 10.593 | 16.053 | 18.876 | 3.216 | 4.796 | 1.466 | 16.380 | 9.519 | 17.126 | 47.357 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 155.132 | 142.589 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftamed Srl